Alpha 2.0
Login Register
» Authors » Sara Strzok

Sara Strzok

Explore the profile of Sara Strzok including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 51
Followers 0
Related Specialties
Health Services
Rehabilitation Medicine
Public Health
Top 10 Co-Authors
Farrah Pompilus
Sophie Cleanthous
Stefan Cano
Patrick Marquis
Juliette Meunier
Shih-Yin Chen
Birgit Haier
Myla D Goldman
Kiren Kresa-Reahl
Thomas Morel
Published In
Mult Scler J Exp Transl Clin
Rheumatol Ther
J Patient Rep Outcomes
Adv Ther
Health Qual Life Outcomes
Affiliations
Soon will be listed here.
Recent Articles
1.
Sleep-loss related to itch in atopic dermatitis: assessing content validity and psychometric properties of a patient-reported sleep-loss rating scale
Rams A, Baldasaro J, Bunod L, Delbecque L, Strzok S, Meunier J, et al.
J Patient Rep Outcomes . 2024 Jul; 8(1):77. PMID: 39039395
Background: Sleep loss is a key factor contributing to disease burden in people with atopic dermatitis (AD). Mitigating itch to improve sleep is an important outcome of AD treatment. This...
2.
Assessing Itch Severity: Content Validity and Psychometric Properties of a Patient-Reported Pruritus Numeric Rating Scale in Atopic Dermatitis
Rams A, Baldasaro J, Bunod L, Delbecque L, Strzok S, Meunier J, et al.
Adv Ther . 2024 Feb; 41(4):1512-1525. PMID: 38363461
Background: Pruritus, or itch, is a key symptom of atopic dermatitis (AD); as such, mitigating itch is an important outcome of AD treatment. This study explored the content validity and...
3.
The Patient and Clinician Assessment of Gastrointestinal (GI) Related Adverse Events Associated with Oral Disease-Modifying Therapies in Multiple Sclerosis: A Qualitative Study
Jivraj F, Kang S, Reedie S, Kapadia S, Strzok S, Elliott E, et al.
Adv Ther . 2022 Sep; 39(11):5072-5086. PMID: 36053450
Introduction: Current guidelines for relapsing-remitting multiple sclerosis (RRMS) call for treatment with disease-modifying therapies (DMTs) early in the disease to prevent relapses and accumulation of neurologic impairment and disability. However,...
4.
Correction to: The Patient Experience of Fatigue in Systemic Lupus Erythematosus: A Conceptual Model
Cleanthous S, Strzok S, Haier B, Cano S, Morel T
Rheumatol Ther . 2021 Nov; 9(1):303. PMID: 34757534
No abstract available.
5.
The Patient Experience of Fatigue in Systemic Lupus Erythematosus: A Conceptual Model
Cleanthous S, Strzok S, Haier B, Cano S, Morel T
Rheumatol Ther . 2021 Oct; 9(1):95-108. PMID: 34622426
Introduction: Fatigue is frequently experienced in systemic lupus erythematosus (SLE) and is a key outcome in clinical research trials. However, SLE fatigue is complex and poorly understood, and challenging to...
6.
Development and psychometric evaluation of the assessment of self-injection questionnaire: an adaptation of the self-injection assessment questionnaire
Pompilus F, Ciesluk A, Strzok S, Ciaravino V, Harris K, Szegvari B, et al.
Health Qual Life Outcomes . 2020 Nov; 18(1):355. PMID: 33148261
Background: Patient-reported outcome (PRO) instruments provide robust and effective means of evaluating patients' treatment experience; however, none adequately cover experience using self-injection devices with enhanced features, such as an electromechanical...
7.
A pragmatic patient-reported outcome strategy for rare disease clinical trials: application of the EORTC item library to myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia
Bell J, Galaznik A, Pompilus F, Strzok S, Bejar R, Scipione F, et al.
J Patient Rep Outcomes . 2019 Jun; 3(1):35. PMID: 31218454
Background: Novel, pragmatic, patient-centered strategies are needed to ensure fit-for-purpose patient-reported outcomes (PRO) instruments in clinical trial research for rare diseases such as myelodysplastic syndromes (MDS), acute myeloid leukemia (AML),...
8.
Development of a gait module to complement the 12-item Multiple Sclerosis Walking Scale: a mixed methods study
Strzok S, Cleanthous S, Pompilus F, Cano S, Marquis P, Cohan S, et al.
Mult Scler J Exp Transl Clin . 2018 Aug; 4(2):2055217318783766. PMID: 30090638
Background And Objective: The 12-item Multiple Sclerosis Walking Scale (MSWS-12) is a patient-reported outcome instrument that quantifies the progressive loss of walking ability from the patient perspective. However, previous psychometric...
9.
Patient Perspective on Acute Intermittent Porphyria with Frequent Attacks: A Disease with Intermittent and Chronic Manifestations
Simon A, Pompilus F, Querbes W, Wei A, Strzok S, Penz C, et al.
Patient . 2018 Jun; 11(5):527-537. PMID: 29915990
Objective: Acute intermittent porphyria is a rare metabolic disorder that affects heme synthesis. Patients with acute intermittent porphyria may experience acute debilitating neurovisceral attacks that require frequent hospitalizations and negatively...
10.
Addressing the targeting range of the ABILHAND-56 in relapsing-remitting multiple sclerosis: A mixed methods psychometric study
Cleanthous S, Strzok S, Pompilus F, Cano S, Marquis P, Cohan S, et al.
Mult Scler J Exp Transl Clin . 2018 May; 4(2):2055217318776990. PMID: 29796290
Background: ABILHAND, a manual ability patient-reported outcome instrument originally developed for stroke patients, has been used in multiple sclerosis clinical trials; however, psychometric analyses indicated the measure's limited measurement range...